Document is current

Article History

Received: 19 February 2024

Accepted: 17 June 2024

First Online: 27 August 2024

Declarations

:

: The study was approved by the Ethics Committee of the Medical Faculty of Heidelberg University (S-604/2022) and conducted in accordance with the Declaration of Helsinki. In this survey study, only anonymised data was documented – neither were participants asked for personal or institutional identifying data, nor were IP addresses saved. Hence, informed consent was waived by the responsible ethics committee. On the first page of the surveys, information on data protection und usage of data was provided and hence, deliberately submitting the survey for evaluation was considered as consent to participate. In contrast, participants of the pilot phase gave individual written consent to participate. Only during the piloting phase of the surveys, participants were identifiable and hence, written informed consent was obtained from all participants of the pilot phase.

: Not applicable.

: Parts of this work were presented at the 49. Scientific Congress of the Federal Association of German Hospital Pharmacists ‘Together and digital - hospital pharmacies in transition’ (Klasing S, Dörje F, Hilgarth H, Metzger N., Richling I, Seidling HM. Krankenhauspharmazie 2024 45:5 (219-251)). The authors filled in the ICMJE disclosure forms for further information. SK reported receiving several honoraria for lectures from chambers of pharmacists. FD reported receiving consulting fees from Lilly Deutschland GmbH and Sandoz Group AG and honoraria for lectures from Lilly Deutschland GmbH. HH declares no competing interests. NM reported receiving several honoraria for lectures from chambers of pharmacists and receiving payment or honoraria for presentations from academy of hospital pharmacy by Federal Association of German Hospital Pharmacists (ADKA) e.V. IR reported receiving consulting fees from Bayer AG and payment or honoraria for oral presentations from several chambers of pharmacists, Deutscher Apotheker Verlag, Rheinische Friedrich-Wilhelms-Universität Bonn, Alliance Healthcare Deutschland GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. She reported receiving payments or honoraria for manuscript writing from Deutscher Apotheker Verlag. HS reported receiving several honoraria from chamber of pharmacists or publishing houses and/or reimbursement for congress visits from professional organisations. Moreover, the Department of Clinical Pharmacology and Pharmacoepidemiology received honoraria from by Boehringer-Ingelheim for a talk she held.